View in EDS

Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study

Saved in:
Bibliographic Details
Title: Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study
Authors: Vuylsteke, P.1 peter.vuylsteke@cmsenamur.be, Huizing, M.2, Petrakova, K.3, Roylance, R.4, Laing, R.5, Chan, S.6, Abell, F.7, Gendreau, S.8, Rooney, I.9, Apt, D.10, Zhou, J.11, Singel, S.9, Fehrenbacher, L.12
Source: Annals of Oncology. Nov2016, Vol. 27 Issue 11, p2059-2066. 8p. 1 Diagram, 3 Charts, 1 Graph.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 119577693
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Vuylsteke%2C+P%2E%22">Vuylsteke, P.</searchLink><relatesTo>1</relatesTo><i> peter.vuylsteke@cmsenamur.be</i><br /><searchLink fieldCode="AR" term="%22Huizing%2C+M%2E%22">Huizing, M.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Petrakova%2C+K%2E%22">Petrakova, K.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Roylance%2C+R%2E%22">Roylance, R.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Laing%2C+R%2E%22">Laing, R.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Chan%2C+S%2E%22">Chan, S.</searchLink><relatesTo>6</relatesTo><br /><searchLink fieldCode="AR" term="%22Abell%2C+F%2E%22">Abell, F.</searchLink><relatesTo>7</relatesTo><br /><searchLink fieldCode="AR" term="%22Gendreau%2C+S%2E%22">Gendreau, S.</searchLink><relatesTo>8</relatesTo><br /><searchLink fieldCode="AR" term="%22Rooney%2C+I%2E%22">Rooney, I.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Apt%2C+D%2E%22">Apt, D.</searchLink><relatesTo>10</relatesTo><br /><searchLink fieldCode="AR" term="%22Zhou%2C+J%2E%22">Zhou, J.</searchLink><relatesTo>11</relatesTo><br /><searchLink fieldCode="AR" term="%22Singel%2C+S%2E%22">Singel, S.</searchLink><relatesTo>9</relatesTo><br /><searchLink fieldCode="AR" term="%22Fehrenbacher%2C+L%2E%22">Fehrenbacher, L.</searchLink><relatesTo>12</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Nov2016, Vol. 27 Issue 11, p2059-2066. 8p. 1 Diagram, 3 Charts, 1 Graph.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=119577693
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdw320
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 2059
    Titles:
      – TitleFull: Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vuylsteke, P.
      – PersonEntity:
          Name:
            NameFull: Huizing, M.
      – PersonEntity:
          Name:
            NameFull: Petrakova, K.
      – PersonEntity:
          Name:
            NameFull: Roylance, R.
      – PersonEntity:
          Name:
            NameFull: Laing, R.
      – PersonEntity:
          Name:
            NameFull: Chan, S.
      – PersonEntity:
          Name:
            NameFull: Abell, F.
      – PersonEntity:
          Name:
            NameFull: Gendreau, S.
      – PersonEntity:
          Name:
            NameFull: Rooney, I.
      – PersonEntity:
          Name:
            NameFull: Apt, D.
      – PersonEntity:
          Name:
            NameFull: Zhou, J.
      – PersonEntity:
          Name:
            NameFull: Singel, S.
      – PersonEntity:
          Name:
            NameFull: Fehrenbacher, L.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1